Janney Montgomery Scott LLC Sage Therapeutics, Inc. Transaction History

Janney Montgomery Scott LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 21, 2020	SELL	$60.18 - $154.77 $241,201 - $620,318	-4,008 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$140.29 - $189.96 $77,019 - $104,288	-549 Reduced 12.05%	4,008 $562,000
Q2 2019 Jul 29, 2019	BUY	$157.85 - $183.09 $34,569 - $40,096	219 Added 5.05%	4,557 $834,000
Q1 2019 Apr 30, 2019	BUY	$89.33 - $163.65 $2,411 - $4,418	27 Added 0.63%	4,338 $690,000
Q4 2018 Feb 01, 2019	SELL	$81.94 - $139.71 $122,582 - $209,006	-1,496 Reduced 25.76%	4,311 $413,000
Q3 2018 Nov 05, 2018	BUY	$138.11 - $169.04 $29,003 - $35,498	210 Added 3.75%	5,807 $820,000
Q2 2018 Jul 24, 2018	BUY	$140.36 - $175.76 $151,588 - $189,820	1,080 Added 23.91%	5,597 $876,000
Q1 2018 Apr 19, 2018	BUY	$152.15 - $192.33 $258,502 - $326,768	1,699 Added 60.29%	4,517 $728,000
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $171,108 - $471,564	2,818	2,818 $464,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.